Inventory Summary of Bio-Techne Corporation

Bio-Techne Corporation's latest annual inventory in 2024 was 179.73 Million USD , up 4.72% from previous year.
Bio-Techne Corporation's latest quarterly inventory in 2024 FY was 179.73 Million USD , up 4.72% from previous quarter.
Bio-Techne Corporation reported annual inventory of 171.63 Million USD in 2023, up 21.62% from previous year.
Bio-Techne Corporation reported annual inventory of 141.12 Million USD in 2022, up 20.88% from previous year.
Bio-Techne Corporation reported quarterly inventory of 179.73 Million USD for 2024 FY, up 4.72% from previous quarter.
Bio-Techne Corporation reported quarterly inventory of 180.83 Million USD for 2024 Q2, down -2.82% from previous quarter.

Annual Inventory Chart of Bio-Techne Corporation (2024 - 1989)

Historical Annual Inventory of Bio-Techne Corporation (2024 - 1989)

Year	Inventory	Inventory Growth
2024	179.73 Million USD	4.72%
2023	171.63 Million USD	21.62%
2022	141.12 Million USD	20.88%
2021	116.74 Million USD	13.18%
2020	103.15 Million USD	13.29%
2019	91.05 Million USD	6.31%
2018	85.64 Million USD	42.39%
2017	60.15 Million USD	5.34%
2016	57.1 Million USD	15.18%
2015	49.57 Million USD	27.62%
2014	38.84 Million USD	11.38%
2013	34.87 Million USD	-8.88%
2012	38.27 Million USD	-14.76%
2011	44.9 Million USD	226.9%
2010	13.73 Million USD	21.9%
2009	11.26 Million USD	18.43%
2008	9.51 Million USD	8.66%
2007	8.75 Million USD	-2.96%
2006	9.02 Million USD	16.32%
2005	7.75 Million USD	4.04%
2004	7.45 Million USD	17.76%
2003	6.33 Million USD	4.2%
2002	6.07 Million USD	11.76%
2001	5.43 Million USD	16.9%
2000	4.65 Million USD	-18.39%
1999	5.7 Million USD	50.0%
1998	3.8 Million USD	-7.32%
1997	4.1 Million USD	10.81%
1996	3.7 Million USD	12.12%
1995	3.3 Million USD	32.0%
1994	2.5 Million USD	47.06%
1993	1.7 Million USD	-22.73%
1992	2.2 Million USD	4.76%
1991	2.1 Million USD	10.53%
1990	1.9 Million USD	18.75%
1989	1.6 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q4	179.73 Million USD	0.13%
2024 FY	179.73 Million USD	4.72%
2024 Q2	180.83 Million USD	-2.82%
2024 Q1	186.08 Million USD	8.41%
2024 Q3	179.49 Million USD	-0.74%
2023 Q4	171.63 Million USD	1.28%
2023 FY	171.63 Million USD	21.62%
2023 Q2	160.23 Million USD	6.82%
2023 Q3	169.46 Million USD	5.76%
2023 Q1	150 Million USD	6.3%
2022 Q2	121.85 Million USD	3.83%
2022 Q1	117.36 Million USD	0.53%
2022 FY	141.12 Million USD	20.88%
2022 Q4	141.12 Million USD	10.01%
2022 Q3	128.28 Million USD	5.27%
2021 Q4	116.74 Million USD	6.14%
2021 Q1	106 Million USD	2.76%
2021 FY	116.74 Million USD	13.18%
2021 Q2	106.59 Million USD	0.55%
2021 Q3	109.99 Million USD	3.19%
2020 Q4	103.15 Million USD	3.49%
2020 FY	103.15 Million USD	13.29%
2020 Q2	95.35 Million USD	4.95%
2020 Q1	90.85 Million USD	-0.21%
2020 Q3	99.67 Million USD	4.53%
2019 FY	91.05 Million USD	6.31%
2019 Q2	90.9 Million USD	-0.01%
2019 Q3	93.83 Million USD	3.23%
2019 Q1	90.91 Million USD	6.15%
2019 Q4	91.05 Million USD	-2.97%
2018 Q2	68.28 Million USD	2.63%
2018 Q4	85.64 Million USD	-3.32%
2018 Q1	66.53 Million USD	10.61%
2018 FY	85.64 Million USD	42.39%
2018 Q3	88.58 Million USD	29.74%
2017 Q1	70.51 Million USD	23.5%
2017 Q2	66.08 Million USD	-6.28%
2017 Q3	63.76 Million USD	-3.51%
2017 Q4	60.15 Million USD	-5.67%
2017 FY	60.15 Million USD	5.34%
2016 Q4	57.1 Million USD	0.06%
2016 Q3	57.06 Million USD	-2.74%
2016 Q2	58.67 Million USD	-0.5%
2016 Q1	58.96 Million USD	18.94%
2016 FY	57.1 Million USD	15.18%
2015 Q2	52.81 Million USD	1.19%
2015 FY	49.57 Million USD	27.62%
2015 Q1	52.19 Million USD	34.36%
2015 Q3	51.04 Million USD	-3.35%
2015 Q4	49.57 Million USD	-2.88%
2014 Q4	38.84 Million USD	1.2%
2014 FY	38.84 Million USD	11.38%
2014 Q1	39.95 Million USD	14.57%
2014 Q2	39.99 Million USD	0.09%
2014 Q3	38.38 Million USD	-4.02%
2013 Q3	35.67 Million USD	-5.12%
2013 Q2	37.6 Million USD	-2.08%
2013 Q1	38.39 Million USD	0.31%
2013 FY	34.87 Million USD	-8.88%
2013 Q4	34.87 Million USD	-2.24%
2012 Q4	38.27 Million USD	-5.48%
2012 Q3	40.49 Million USD	-1.17%
2012 Q2	40.97 Million USD	-2.7%
2012 FY	38.27 Million USD	-14.76%
2012 Q1	42.11 Million USD	-6.21%
2011 Q4	44.9 Million USD	229.73%
2011 Q1	13.81 Million USD	0.59%
2011 Q2	13.73 Million USD	-0.59%
2011 Q3	13.61 Million USD	-0.85%
2011 FY	44.9 Million USD	226.9%
2010 Q4	13.73 Million USD	2.13%
2010 FY	13.73 Million USD	21.9%
2010 Q3	13.45 Million USD	3.56%
2010 Q2	12.98 Million USD	4.17%
2010 Q1	12.46 Million USD	10.64%
2009 Q1	9.69 Million USD	1.93%
2009 Q4	11.26 Million USD	4.84%
2009 FY	11.26 Million USD	18.43%
2009 Q3	10.74 Million USD	8.83%
2009 Q2	9.87 Million USD	1.84%
2008 Q2	9.4 Million USD	1.38%
2008 Q3	10 Million USD	6.31%
2008 FY	9.51 Million USD	8.66%
2008 Q1	9.28 Million USD	5.98%
2008 Q4	9.51 Million USD	-4.88%
2007 Q1	8.98 Million USD	-0.47%
2007 Q2	9.21 Million USD	2.54%
2007 FY	8.75 Million USD	-2.96%
2007 Q3	9.57 Million USD	3.95%
2007 Q4	8.75 Million USD	-8.53%
2006 Q2	9.95 Million USD	-0.32%
2006 Q3	9.6 Million USD	-3.47%
2006 Q4	9.02 Million USD	-6.05%
2006 FY	9.02 Million USD	16.32%
2006 Q1	9.98 Million USD	28.67%
2005 Q1	7.87 Million USD	5.59%
2005 FY	7.75 Million USD	4.04%
2005 Q3	8.22 Million USD	1.86%
2005 Q2	8.07 Million USD	2.6%
2005 Q4	7.75 Million USD	-5.72%
2004 FY	7.45 Million USD	17.76%
2004 Q3	7.29 Million USD	2.11%
2004 Q2	7.14 Million USD	8.19%
2004 Q1	6.6 Million USD	4.28%
2004 Q4	7.45 Million USD	2.22%
2003 Q1	6.17 Million USD	1.63%
2003 FY	6.33 Million USD	4.2%
2003 Q4	6.33 Million USD	-3.45%
2003 Q3	6.55 Million USD	0.32%
2003 Q2	6.53 Million USD	5.85%
2002 Q2	5.98 Million USD	1.55%
2002 FY	6.07 Million USD	11.76%
2002 Q4	6.07 Million USD	2.18%
2002 Q3	5.94 Million USD	-0.55%
2002 Q1	5.88 Million USD	8.31%
2001 Q4	5.43 Million USD	6.83%
2001 Q3	5.08 Million USD	4.84%
2001 Q1	4.53 Million USD	-2.43%
2001 Q2	4.85 Million USD	6.97%
2001 FY	5.43 Million USD	16.9%
2000 Q3	4.33 Million USD	3.26%
2000 Q1	5.1 Million USD	-10.53%
2000 FY	4.65 Million USD	-18.39%
2000 Q4	4.65 Million USD	7.26%
2000 Q2	4.2 Million USD	-17.65%
1999 Q3	7.2 Million USD	-16.28%
1999 Q4	5.7 Million USD	-20.83%
1999 Q2	8.6 Million USD	-6.52%
1999 Q1	9.2 Million USD	142.11%
1999 FY	5.7 Million USD	50.0%
1998 Q4	3.8 Million USD	-2.56%
1998 Q3	3.9 Million USD	-2.5%
1998 Q2	4 Million USD	-2.44%
1998 FY	3.8 Million USD	-7.32%
1998 Q1	4.1 Million USD	0.0%
1997 Q2	4.1 Million USD	10.81%
1997 FY	4.1 Million USD	10.81%
1997 Q4	4.1 Million USD	2.5%
1997 Q1	3.7 Million USD	0.0%
1997 Q3	4 Million USD	-2.44%
1996 Q4	3.7 Million USD	12.12%
1996 FY	3.7 Million USD	12.12%
1996 Q3	3.3 Million USD	0.0%
1996 Q2	3.3 Million USD	-2.94%
1996 Q1	3.4 Million USD	3.03%
1995 Q1	2.3 Million USD	-8.0%
1995 FY	3.3 Million USD	32.0%
1995 Q4	3.3 Million USD	13.79%
1995 Q3	2.9 Million USD	11.54%
1995 Q2	2.6 Million USD	13.04%
1994 Q4	2.5 Million USD	0.0%
1994 Q1	2.5 Million USD	47.06%
1994 Q2	2.6 Million USD	4.0%
1994 Q3	2.5 Million USD	-3.85%
1994 FY	2.5 Million USD	47.06%
1993 FY	1.7 Million USD	-22.73%
1993 Q2	2.1 Million USD	0.0%
1993 Q3	1.7 Million USD	-19.05%
1993 Q4	1.7 Million USD	0.0%
1993 Q1	2.1 Million USD	-4.55%
1992 Q4	2.2 Million USD	0.0%
1992 FY	2.2 Million USD	4.76%
1992 Q1	4.2 Million USD	100.0%
1992 Q2	2.6 Million USD	-38.1%
1992 Q3	2.2 Million USD	-15.38%
1991 Q4	2.1 Million USD	5.0%
1991 Q3	2 Million USD	-9.09%
1991 Q2	2.2 Million USD	4.76%
1991 Q1	2.1 Million USD	10.53%
1991 FY	2.1 Million USD	10.53%
1990 FY	1.9 Million USD	18.75%
1990 Q4	1.9 Million USD	5.56%
1990 Q3	1.8 Million USD	12.5%
1990 Q2	1.6 Million USD	-11.11%
1990 Q1	1.8 Million USD	0.0%
1989 FY	1.6 Million USD	0.0%

Peer Inventory Comparison of Bio-Techne Corporation

Name	Inventory	Inventory Difference
Absci Corporation	- USD	-Infinity%
Adaptive Biotechnologies Corporation	14.44 Million USD	-1143.985%
Alnylam Pharmaceuticals, Inc.	89.14 Million USD	-101.614%
Alzamend Neuro, Inc.	- USD	-Infinity%
Apollomics, Inc.	-466 Thousand USD	38668.884%
180 Life Sciences Corp.	- USD	-Infinity%
Atossa Therapeutics, Inc.	1.48 Million USD	-11986.819%
Bicycle Therapeutics plc	- USD	-Infinity%
Barinthus Biotherapeutics plc	1.00 USD	-17973099900.0%
BioXcel Therapeutics, Inc.	1.99 Million USD	-8927.172%
CASI Pharmaceuticals, Inc.	15.87 Million USD	-1032.021%
Chimerix, Inc.	- USD	-Infinity%
CRISPR Therapeutics AG	- USD	-Infinity%
Contineum Therapeutics, Inc. Class A Common Stock	- USD	-Infinity%
EyePoint Pharmaceuticals, Inc.	3.9 Million USD	-4501.408%
Fortress Biotech, Inc.	10.2 Million USD	-1661.033%
Fortress Biotech, Inc.	10.2 Million USD	-1661.033%
Gritstone bio, Inc.	- USD	-Infinity%
Allakos Inc.	- USD	-Infinity%
Boundless Bio, Inc. Common Stock	- USD	-Infinity%
Cara Therapeutics, Inc.	2.82 Million USD	-6271.18%
Cytokinetics, Incorporated	- USD	-Infinity%
enGene Holdings Inc. Common Stock	76 Thousand USD	-236388.158%
Innoviva, Inc.	40.73 Million USD	-341.198%
Hoth Therapeutics, Inc.	- USD	-Infinity%
NLS Pharmaceutics AG	- USD	-Infinity%
RAPT Therapeutics, Inc.	- USD	-Infinity%
Salarius Pharmaceuticals, Inc.	- USD	-Infinity%
Terns Pharmaceuticals, Inc.	- USD	-Infinity%
Vigil Neuroscience, Inc.	- USD	-Infinity%
ImmuCell Corporation	7.81 Million USD	-2200.751%
IDEAYA Biosciences, Inc.	532.61 Million USD	66.255%
Incyte Corporation	62.97 Million USD	-185.414%
Inovio Pharmaceuticals, Inc.	- USD	-Infinity%
Lexaria Bioscience Corp.	1.00 USD	-17973099900.0%
Mustang Bio, Inc.	- USD	-Infinity%
MiMedx Group, Inc.	21.02 Million USD	-755.007%
MEI Pharma, Inc.	- USD	-Infinity%
MacroGenics, Inc.	1.22 Million USD	-14619.984%
Monopar Therapeutics Inc.	- USD	-Infinity%
Mereo BioPharma Group plc	1.24 Million USD	-14313.071%
Marker Therapeutics, Inc.	1.00 USD	-17973099900.0%
Marinus Pharmaceuticals, Inc.	2.41 Million USD	-7348.446%
Maravai LifeSciences Holdings, Inc.	51.39 Million USD	-249.692%
Minerva Neurosciences, Inc.	- USD	-Infinity%
NeuroBo Pharmaceuticals, Inc.	- USD	-Infinity%
NeuroSense Therapeutics Ltd.	- USD	-Infinity%
NextCure, Inc.	- USD	-Infinity%
Orchestra BioMed Holdings, Inc.	146 Thousand USD	-123003.425%
Ocuphire Pharma, Inc.	- USD	-Infinity%
Onconetix, Inc.	364.05 Thousand USD	-49269.596%
Oncternal Therapeutics, Inc.	1.00 USD	-17973099900.0%
Opthea Limited	- USD	-Infinity%
Ovid Therapeutics Inc.	- USD	-Infinity%
Psyence Biomedical Ltd.	- USD	-Infinity%
PDS Biotechnology Corporation	- USD	-Infinity%
Precigen, Inc.	1.00 USD	-17973099900.0%
Pieris Pharmaceuticals, Inc.	4.08 Million USD	-4297.628%
Prime Medicine, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Rocket Pharmaceuticals, Inc.	- USD	-Infinity%
Regeneron Pharmaceuticals, Inc.	2.58 Billion USD	93.035%
Replimune Group, Inc.	- USD	-Infinity%
Revelation Biosciences, Inc.	- USD	-Infinity%
Rigel Pharmaceuticals, Inc.	5.52 Million USD	-3154.817%
TransCode Therapeutics, Inc.	- USD	-Infinity%
Revolution Medicines, Inc. Warrant	1.00 USD	-17973099900.0%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Sesen Bio, Inc.	21 Million USD	-755.862%
Sangamo Therapeutics, Inc.	- USD	-Infinity%
Solid Biosciences Inc.	- USD	-Infinity%
Syndax Pharmaceuticals, Inc.	2 Million USD	-8873.09%
SciSparc Ltd.	742 Thousand USD	-24122.507%
Sutro Biopharma, Inc.	1.00 USD	-17973099900.0%
TG Therapeutics, Inc.	39.82 Million USD	-351.325%
Tonix Pharmaceuticals Holding Corp.	14.14 Million USD	-1170.453%
Titan Pharmaceuticals, Inc.	- USD	-Infinity%
Travere Therapeutics, Inc.	9.41 Million USD	-1810.0%
UroGen Pharma Ltd.	5.67 Million USD	-3068.183%
Verrica Pharmaceuticals Inc.	1.02 Million USD	-17486.204%
XOMA Corporation	1.00 USD	-17973099900.0%
Zentalis Pharmaceuticals, Inc.	- USD	-Infinity%
AbCellera Biologics Inc.	1.1 Million USD	-16135.863%
Longboard Pharmaceuticals, Inc.	- USD	-Infinity%
Cassava Sciences, Inc.	- USD	-Infinity%
Corbus Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Precision BioSciences, Inc.	- USD	-Infinity%
Dyadic International, Inc.	1.00 USD	-17973099900.0%
Intensity Therapeutics, Inc.	- USD	-Infinity%
Eton Pharmaceuticals, Inc.	911 Thousand USD	-19628.979%
VYNE Therapeutics Inc.	- USD	-Infinity%
Tenaya Therapeutics, Inc.	- USD	-Infinity%
IGM Biosciences, Inc.	- USD	-Infinity%
X4 Pharmaceuticals, Inc.	- USD	-Infinity%
Acelyrin, Inc.	8.85 Million USD	-1930.629%
Abeona Therapeutics Inc.	- USD	-Infinity%
Ligand Pharmaceuticals Incorporated	23.96 Million USD	-649.848%
Inhibikase Therapeutics, Inc.	- USD	-Infinity%
Arcturus Therapeutics Holdings Inc.	1.00 USD	-17973099900.0%
Syros Pharmaceuticals, Inc.	- USD	-Infinity%
Senti Biosciences, Inc.	- USD	-Infinity%
Mesoblast Limited	- USD	-Infinity%
Kymera Therapeutics, Inc.	1.00 USD	-17973099900.0%
ChromaDex Corporation	14.52 Million USD	-1137.391%
BriaCell Therapeutics Corp.	-1.36 Million USD	13228.481%
Akebia Therapeutics, Inc.	15.69 Million USD	-1045.44%
Dermata Therapeutics, Inc.	- USD	-Infinity%
Seer, Inc.	4.49 Million USD	-3902.026%
Xeris Biopharma Holdings, Inc.	38.83 Million USD	-362.771%
Novavax, Inc.	41.69 Million USD	-331.051%
Virpax Pharmaceuticals, Inc.	- USD	-Infinity%
Fate Therapeutics, Inc.	- USD	-Infinity%
Checkpoint Therapeutics, Inc.	- USD	-Infinity%
Lyell Immunopharma, Inc.	- USD	-Infinity%
Celcuity Inc.	- USD	-Infinity%
ContextLogic Inc.	- USD	-Infinity%
Phathom Pharmaceuticals, Inc.	1.2 Million USD	-14778.394%
HOOKIPA Pharma Inc.	- USD	-Infinity%
Jazz Pharmaceuticals plc	597.03 Million USD	69.896%
Amarin Corporation plc	258.61 Million USD	30.503%
AnaptysBio, Inc.	1.00 USD	-17973099900.0%
Aptevo Therapeutics Inc.	- USD	-Infinity%
Aptorum Group Limited	- USD	-Infinity%
Cartesian Therapeutics, Inc.	- USD	-Infinity%
Arrowhead Pharmaceuticals, Inc.	- USD	-Infinity%
Ardelyx, Inc.	12.44 Million USD	-1343.854%
Celularity Inc.	5.75 Million USD	-3024.127%
Omeros Corporation	8.58 Million USD	-1994.523%
Humacyte, Inc.	- USD	-Infinity%
Immunocore Holdings plc	4.5 Million USD	-3893.135%
IO Biotech, Inc.	- USD	-Infinity%
GT Biopharma, Inc.	- USD	-Infinity%
Cabaletta Bio, Inc.	- USD	-Infinity%
Summit Therapeutics Inc.	2.44 Million USD	-7263.007%
Alaunos Therapeutics, Inc.	- USD	-Infinity%
Pulmatrix, Inc.	- USD	-Infinity%
Intellia Therapeutics, Inc.	- USD	-Infinity%
Evogene Ltd.	1.69 Million USD	-10516.125%
CorMedix Inc.	2.1 Million USD	-8432.838%
BioLineRx Ltd.	1.95 Million USD	-9102.816%
VistaGen Therapeutics, Inc.	- USD	-Infinity%
Sagimet Biosciences Inc.	- USD	-Infinity%
PTC Therapeutics, Inc.	30.57 Million USD	-487.798%
scPharmaceuticals Inc.	8.84 Million USD	-1933.156%
Fulcrum Therapeutics, Inc.	- USD	-Infinity%
Corcept Therapeutics Incorporated	7.73 Million USD	-2225.11%
NLS Pharmaceutics AG	- USD	-Infinity%
Reviva Pharmaceuticals Holdings, Inc.	- USD	-Infinity%
Akero Therapeutics, Inc.	- USD	-Infinity%
Eliem Therapeutics, Inc.	- USD	-Infinity%
Lisata Therapeutics, Inc.	- USD	-Infinity%
Stoke Therapeutics, Inc.	- USD	-Infinity%
Reneo Pharmaceuticals, Inc.	- USD	-Infinity%
Outlook Therapeutics, Inc.	- USD	-Infinity%
ProMIS Neurosciences, Inc.	- USD	-Infinity%
Daré Bioscience, Inc.	- USD	-Infinity%
bluebird bio, Inc.	22.91 Million USD	-684.201%
BioMarin Pharmaceutical Inc.	1.1 Billion USD	83.767%
DBV Technologies S.A.	- USD	-Infinity%
Avidity Biosciences, Inc.	- USD	-Infinity%
Galecto, Inc.	1.00 USD	-17973099900.0%
Sensei Biotherapeutics, Inc.	- USD	-Infinity%
Spruce Biosciences, Inc.	- USD	-Infinity%
Inhibrx Biosciences, Inc.	- USD	-Infinity%
GlycoMimetics, Inc.	- USD	-Infinity%
Arcutis Biotherapeutics, Inc.	13.13 Million USD	-1268.441%
ADMA Biologics, Inc.	172.9 Million USD	-3.947%
Clene Inc.	37 Thousand USD	-485659.459%
Recursion Pharmaceuticals, Inc.	-3.09 Million USD	5909.017%
Aptose Biosciences Inc.	- USD	-Infinity%
ZyVersa Therapeutics, Inc.	- USD	-Infinity%
Soligenix, Inc.	1.00 USD	-17973099900.0%
Century Therapeutics, Inc.	- USD	-Infinity%
Kura Oncology, Inc.	- USD	-Infinity%
Surrozen, Inc.	1.00 USD	-17973099900.0%
TScan Therapeutics, Inc.	- USD	-Infinity%
Ocean Biomedical, Inc.	- USD	-Infinity%
CytomX Therapeutics, Inc.	- USD	-Infinity%
Autolus Therapeutics plc	-24.54 Million USD	832.34%
Mineralys Therapeutics, Inc.	- USD	-Infinity%
Eterna Therapeutics Inc.	- USD	-Infinity%
Caribou Biosciences, Inc.	- USD	-Infinity%
GRI Bio, Inc.	- USD	-Infinity%
Xenetic Biosciences, Inc.	- USD	-Infinity%
Janux Therapeutics, Inc.	-2.2 Million USD	8269.591%
INmune Bio, Inc.	- USD	-Infinity%
Heron Therapeutics, Inc.	42.11 Million USD	-326.813%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	443880.247%
Tenax Therapeutics, Inc.	- USD	-Infinity%
Jaguar Health, Inc.	9.18 Million USD	-1855.936%
Entero Therapeutics, Inc.	- USD	-Infinity%
Milestone Pharmaceuticals Inc.	- USD	-Infinity%
Clearside Biomedical, Inc.	1.00 USD	-17973099900.0%
Atara Biotherapeutics, Inc.	9.7 Million USD	-1751.751%
Coherus BioSciences, Inc.	62.6 Million USD	-187.087%
Verastem, Inc.	- USD	-Infinity%
Pliant Therapeutics, Inc.	- USD	-Infinity%
Histogen Inc.	400 Thousand USD	-44832.75%
Aprea Therapeutics, Inc.	- USD	-Infinity%
ACADIA Pharmaceuticals Inc.	35.81 Million USD	-401.776%
Surrozen, Inc.	1.00 USD	-17973099900.0%
Organovo Holdings, Inc.	297 Thousand USD	-60415.488%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Cadrenal Therapeutics, Inc. Common Stock	- USD	-Infinity%
Centessa Pharmaceuticals plc	1.00 USD	-17973099900.0%
Hepion Pharmaceuticals, Inc.	- USD	-Infinity%
BioRestorative Therapies, Inc.	1.00 USD	-17973099900.0%
Kronos Bio, Inc.	- USD	-Infinity%
Turnstone Biologics Corp.	4.77 Million USD	-3667.156%
Synaptogenix, Inc.	- USD	-Infinity%
Tiziana Life Sciences Ltd	- USD	-Infinity%
Entrada Therapeutics, Inc.	1.00 USD	-17973099900.0%
Aurinia Pharmaceuticals Inc.	39.7 Million USD	-352.666%
Exelixis, Inc.	17.32 Million USD	-937.528%
Nurix Therapeutics, Inc.	- USD	-Infinity%
Apellis Pharmaceuticals, Inc.	146.36 Million USD	-22.799%
Jasper Therapeutics, Inc.	- USD	-Infinity%
ESSA Pharma Inc.	- USD	-Infinity%
TNF Pharmaceuticals, Inc.	- USD	-Infinity%
Avid Bioservices, Inc.	30.37 Million USD	-491.707%
Insmed Incorporated	83.24 Million USD	-115.898%
MediWound Ltd.	2.84 Million USD	-6215.214%
OmniAb, Inc.	1.00 USD	-17973099900.0%
Alector, Inc.	- USD	-Infinity%
Seres Therapeutics, Inc.	29.64 Million USD	-506.237%
Zai Lab Limited	44.82 Million USD	-300.944%
AlloVir, Inc.	- USD	-Infinity%
Revance Therapeutics, Inc.	45.57 Million USD	-294.329%
ORIC Pharmaceuticals, Inc.	- USD	-Infinity%
Aura Biosciences, Inc.	- USD	-Infinity%
Immunic, Inc.	- USD	-Infinity%
Tarsus Pharmaceuticals, Inc.	3.1 Million USD	-5684.712%
Veracyte, Inc.	16.12 Million USD	-1014.404%
InMed Pharmaceuticals Inc.	1.24 Million USD	-14344.068%
FibroGen, Inc.	41.56 Million USD	-332.409%
SeaStar Medical Holding Corporation	- USD	-Infinity%
Catalyst Pharmaceuticals, Inc.	15.64 Million USD	-1048.881%
Adial Pharmaceuticals, Inc.	- USD	-Infinity%
Sonnet BioTherapeutics Holdings, Inc.	- USD	-Infinity%
Cyclacel Pharmaceuticals, Inc.	- USD	-Infinity%
Amylyx Pharmaceuticals, Inc.	38.32 Million USD	-368.99%
Fortrea Holdings Inc.	35.3 Million USD	-409.153%
KalVista Pharmaceuticals, Inc.	- USD	-Infinity%
XBiotech Inc.	- USD	-Infinity%
Jasper Therapeutics, Inc.	- USD	-Infinity%
Keros Therapeutics, Inc.	14.05 Million USD	-1178.86%
SELLAS Life Sciences Group, Inc.	- USD	-Infinity%
Lyra Therapeutics, Inc.	- USD	-Infinity%
Foghorn Therapeutics Inc.	- USD	-Infinity%
Agenus Inc.	1.00 USD	-17973099900.0%
Y-mAbs Therapeutics, Inc.	5.06 Million USD	-3448.49%
Theravance Biopharma, Inc.	1.00 USD	-17973099900.0%
Ultragenyx Pharmaceutical Inc.	33.96 Million USD	-429.103%
Metagenomi, Inc. Common Stock	- USD	-Infinity%
BioCryst Pharmaceuticals, Inc.	28.68 Million USD	-526.612%
Gain Therapeutics, Inc.	- USD	-Infinity%
C4 Therapeutics, Inc.	- USD	-Infinity%
Creative Medical Technology Holdings, Inc.	6594.00 USD	-2725574.856%
Chemomab Therapeutics Ltd.	-1.03 Million USD	17431.739%
Lantern Pharma Inc.	- USD	-Infinity%
Eledon Pharmaceuticals, Inc.	- USD	-Infinity%
Ainos, Inc.	167.59 Thousand USD	-107142.546%
Pluri Inc.	222 Thousand USD	-80859.91%
Prothena Corporation plc	-5.15 Million USD	3583.834%
Adaptimmune Therapeutics plc	1.32 Million USD	-13423.777%
Rallybio Corporation	- USD	-Infinity%
Kodiak Sciences Inc.	- USD	-Infinity%
Cue Biopharma, Inc.	1.00 USD	-17973099900.0%
MeiraGTx Holdings plc	- USD	-Infinity%
Annexon, Inc.	- USD	-Infinity%
Assembly Biosciences, Inc.	1.00 USD	-17973099900.0%
Moderna, Inc.	202 Million USD	11.024%
Cocrystal Pharma, Inc.	- USD	-Infinity%
Cidara Therapeutics, Inc.	6.09 Million USD	-2847.86%
Blueprint Medicines Corporation	21.22 Million USD	-746.869%
Immix Biopharma, Inc.	- USD	-Infinity%
CalciMedica, Inc.	- USD	-Infinity%
Monte Rosa Therapeutics, Inc.	- USD	-Infinity%
Scholar Rock Holding Corporation	- USD	-Infinity%
Wave Life Sciences Ltd.	1.00 USD	-17973099900.0%
Sana Biotechnology, Inc.	- USD	-Infinity%
Elicio Therapeutics, Inc.	- USD	-Infinity%
Adlai Nortye Ltd. American Depositary Shares	1.00 USD	-17973099900.0%
Nutriband Inc.	168.6 Thousand USD	-106498.855%
Protara Therapeutics, Inc.	- USD	-Infinity%
Vor Biopharma Inc.	- USD	-Infinity%
Roivant Sciences Ltd.	35.25 Million USD	-409.861%
Alkermes plc	186.4 Million USD	3.581%
ProKidney Corp.	- USD	-Infinity%
Applied Therapeutics, Inc.	- USD	-Infinity%
Arcellx, Inc.	- USD	-Infinity%
BridgeBio Pharma, Inc.	16.65 Million USD	-979.271%
Tango Therapeutics, Inc.	- USD	-Infinity%
Galectin Therapeutics Inc.	- USD	-Infinity%
Atai Life Sciences N.V.	1.00 USD	-17973099900.0%
Renovaro Biosciences Inc.	-439.31 Thousand USD	41011.367%
Aerovate Therapeutics, Inc.	- USD	-Infinity%
MediciNova, Inc.	- USD	-Infinity%
Praxis Precision Medicines, Inc.	- USD	-Infinity%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
GeoVax Labs, Inc.	- USD	-Infinity%
Axsome Therapeutics, Inc.	15.13 Million USD	-1087.519%
Biomea Fusion, Inc.	- USD	-Infinity%
RenovoRx, Inc.	- USD	-Infinity%
Cullinan Oncology, Inc.	-5.4 Million USD	3428.352%
Geron Corporation	- USD	-Infinity%
NRx Pharmaceuticals, Inc.	-6000.00 USD	2995616.667%
4D Molecular Therapeutics, Inc.	- USD	-Infinity%
Dyne Therapeutics, Inc.	- USD	-Infinity%
Kiniksa Pharmaceuticals, Ltd.	31.12 Million USD	-477.505%
Royalty Pharma plc	- USD	-Infinity%
Ventyx Biosciences, Inc.	-800 Thousand USD	22566.375%
Imunon, Inc.	- USD	-Infinity%
BioAtla, Inc.	- USD	-Infinity%
Allogene Therapeutics, Inc.	-1.7 Million USD	10672.412%
Larimar Therapeutics, Inc.	- USD	-Infinity%
Mersana Therapeutics, Inc.	- USD	-Infinity%
Structure Therapeutics Inc.	- USD	-Infinity%
89bio, Inc.	- USD	-Infinity%
Kezar Life Sciences, Inc.	- USD	-Infinity%
aTyr Pharma, Inc.	- USD	-Infinity%
Aligos Therapeutics, Inc.	- USD	-Infinity%
Viridian Therapeutics, Inc.	- USD	-Infinity%
EyeGate Pharmaceuticals, Inc.	- USD	-Infinity%
Akari Therapeutics, Plc	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Halozyme Therapeutics, Inc.	127.6 Million USD	-40.854%
Lexicon Pharmaceuticals, Inc.	381 Thousand USD	-47073.491%
Liquidia Corporation	1.00 USD	-17973099900.0%
Entera Bio Ltd.	- USD	-Infinity%
GH Research PLC	-178 Thousand USD	101072.472%
Vericel Corporation	13.08 Million USD	-1273.355%
Arbutus Biopharma Corporation	-1.77 Million USD	10219.989%
Xencor, Inc.	-11.29 Million USD	1691.949%
60 Degrees Pharmaceuticals, Inc.	466.16 Thousand USD	-38454.902%
Pasithea Therapeutics Corp.	-40.5 Thousand USD	443880.247%
Coeptis Therapeutics Holdings, Inc.	- USD	-Infinity%
Vaxcyte, Inc.	-6.15 Million USD	3018.185%
Xenon Pharmaceuticals Inc.	1.00 USD	-17973099900.0%
Vanda Pharmaceuticals Inc.	1.35 Million USD	-13144.731%
Lexaria Bioscience Corp.	1.00 USD	-17973099900.0%
Portage Biotech Inc.	- USD	-Infinity%
Cardio Diagnostics Holdings, Inc.	- USD	-Infinity%
Olema Pharmaceuticals, Inc.	- USD	-Infinity%
OncoCyte Corporation	- USD	-Infinity%
Qualigen Therapeutics, Inc.	- USD	-Infinity%
Processa Pharmaceuticals, Inc.	- USD	-Infinity%
Purple Biotech Ltd.	- USD	-Infinity%
Tempest Therapeutics, Inc.	- USD	-Infinity%
Sol-Gel Technologies Ltd.	- USD	-Infinity%
Rhythm Pharmaceuticals, Inc.	8.62 Million USD	-1984.079%
CollPlant Biotechnologies Ltd.	714 Thousand USD	-25072.409%
Moleculin Biotech, Inc.	- USD	-Infinity%
United Therapeutics Corporation	111.8 Million USD	-60.761%
HilleVax, Inc.	- USD	-Infinity%
Silo Pharma, Inc.	- USD	-Infinity%
Telomir Pharmaceuticals, Inc. Common Stock	303.28 Thousand USD	-59162.202%
Pharming Group N.V.	56.76 Million USD	-216.651%
Tharimmune, Inc.	- USD	-Infinity%
Genprex, Inc.	- USD	-Infinity%
Apogee Therapeutics, Inc.	- USD	-Infinity%
Neumora Therapeutics, Inc. Common Stock	- USD	-Infinity%
Pyxis Oncology, Inc.	- USD	-Infinity%
XTL Biopharmaceuticals Ltd.	- USD	-Infinity%
Virios Therapeutics, Inc.	- USD	-Infinity%
OKYO Pharma Limited	- USD	-Infinity%
Savara Inc.	1.00 USD	-17973099900.0%
Windtree Therapeutics, Inc.	- USD	-Infinity%
Curis, Inc.	- USD	-Infinity%
Carmell Therapeutics Corporation	- USD	-Infinity%
Achieve Life Sciences, Inc.	- USD	-Infinity%
BeiGene, Ltd.	416.12 Million USD	56.808%
Protagonist Therapeutics, Inc.	-10.33 Million USD	1839.557%
Erasca, Inc.	- USD	-Infinity%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
Protagenic Therapeutics, Inc.	- USD	-Infinity%
Vincerx Pharma, Inc.	- USD	-Infinity%
Fresh Tracks Therapeutics, Inc.	545 Thousand USD	-32878.165%
Acrivon Therapeutics, Inc. Common Stock	- USD	-Infinity%
Celldex Therapeutics, Inc.	1.00 USD	-17973099900.0%
Cogent Biosciences, Inc.	- USD	-Infinity%
Adicet Bio, Inc.	- USD	-Infinity%
Amicus Therapeutics, Inc.	59.69 Million USD	-201.077%
Aditxt, Inc.	745.5 Thousand USD	-24008.721%
Adagene Inc.	- USD	-Infinity%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	62342.131%
Quantum-Si incorporated	3.94 Million USD	-4455.919%
Acurx Pharmaceuticals, Inc.	- USD	-Infinity%
Voyager Therapeutics, Inc.	1.00 USD	-17973099900.0%
Compugen Ltd.	- USD	-Infinity%
Generation Bio Co.	3.81 Million USD	-4609.932%
Astria Therapeutics, Inc.	- USD	-Infinity%
Black Diamond Therapeutics, Inc.	- USD	-Infinity%
Invivyd, Inc.	- USD	-Infinity%
Relay Therapeutics, Inc.	- USD	-Infinity%
Quoin Pharmaceuticals, Ltd.	- USD	-Infinity%
Spero Therapeutics, Inc.	1.00 USD	-17973099900.0%
Artelo Biosciences, Inc.	- USD	-Infinity%
2seventy bio, Inc.	-13.41 Million USD	1440.176%
Instil Bio, Inc.	- USD	-Infinity%
Capricor Therapeutics, Inc.	1.00 USD	-17973099900.0%
Elevai Labs, Inc. Common Stock	598.78 Thousand USD	-29915.849%
GeoVax Labs, Inc.	- USD	-Infinity%
Citius Pharmaceuticals, Inc.	- USD	-Infinity%
Relmada Therapeutics, Inc.	- USD	-Infinity%
ALX Oncology Holdings Inc.	- USD	-Infinity%
Vir Biotechnology, Inc.	- USD	-Infinity%
Evaxion Biotech A/S	- USD	-Infinity%
Ocular Therapeutix, Inc.	2.3 Million USD	-7697.44%
Verve Therapeutics, Inc.	1.00 USD	-17973099900.0%
Tyra Biosciences, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	1229282.054%
Galmed Pharmaceuticals Ltd.	- USD	-Infinity%
Unity Biotechnology, Inc.	- USD	-Infinity%
Connect Biopharma Holdings Limited	-13.95 Million USD	1388.329%
Clearmind Medicine Inc.	-11.39 Thousand USD	1577504.095%
Bolt Biotherapeutics, Inc.	- USD	-Infinity%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
Viking Therapeutics, Inc.	- USD	-Infinity%
Madrigal Pharmaceuticals, Inc.	- USD	-Infinity%
ImmunityBio, Inc.	- USD	-Infinity%
Korro Bio, Inc.	- USD	-Infinity%
Kineta, Inc.	- USD	-Infinity%
BioVie Inc.	- USD	-Infinity%
Codexis, Inc.	2.68 Million USD	-6593.892%
Celularity Inc.	5.75 Million USD	-3024.127%
Aileron Therapeutics, Inc.	- USD	-Infinity%
Crinetics Pharmaceuticals, Inc.	- USD	-Infinity%
Virax Biolabs Group Limited	60.38 Thousand USD	-297551.657%
Cibus, Inc.	- USD	-Infinity%
IN8bio, Inc.	- USD	-Infinity%
Adverum Biotechnologies, Inc.	- USD	-Infinity%
Avalo Therapeutics, Inc.	- USD	-Infinity%
Ionis Pharmaceuticals, Inc.	28.42 Million USD	-532.299%
Eyenovia, Inc.	109.79 Thousand USD	-163592.417%
Puma Biotechnology, Inc.	7.08 Million USD	-2438.573%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
Elevation Oncology, Inc.	- USD	-Infinity%
Xilio Therapeutics, Inc.	- USD	-Infinity%
Cardiff Oncology, Inc.	- USD	-Infinity%
Enanta Pharmaceuticals, Inc.	- USD	-Infinity%
Regulus Therapeutics Inc.	3010.00 USD	-5971029.568%
Moolec Science SA	465.74 Thousand USD	-38489.752%
Acumen Pharmaceuticals, Inc.	98 Thousand USD	-183298.98%
LAVA Therapeutics N.V.	- USD	-Infinity%
Atea Pharmaceuticals, Inc.	- USD	-Infinity%
Compass Therapeutics, Inc.	- USD	-Infinity%
Greenwich LifeSciences, Inc.	- USD	-Infinity%
TFF Pharmaceuticals, Inc.	- USD	-Infinity%
Humacyte, Inc.	- USD	-Infinity%
PMV Pharmaceuticals, Inc.	- USD	-Infinity%
Avenue Therapeutics, Inc.	- USD	-Infinity%
Genelux Corporation	- USD	-Infinity%
Trevi Therapeutics, Inc.	- USD	-Infinity%
Notable Labs, Ltd.	2.88 Million USD	-6125.528%
Immunovant, Inc.	- USD	-Infinity%
Quantum-Si incorporated	3.94 Million USD	-4455.919%
DiaMedica Therapeutics Inc.	- USD	-Infinity%
Vera Therapeutics, Inc.	- USD	-Infinity%
Acasti Pharma Inc.	- USD	-Infinity%
MiNK Therapeutics, Inc.	- USD	-Infinity%
Soleno Therapeutics, Inc.	- USD	-Infinity%
PepGen Inc.	- USD	-Infinity%
Nuvectis Pharma, Inc.	- USD	-Infinity%
BriaCell Therapeutics Corp.	-1.36 Million USD	13222.998%
Immuneering Corporation	- USD	-Infinity%
Lixte Biotechnology Holdings, Inc.	- USD	-Infinity%
Belite Bio, Inc	- USD	-Infinity%
XOMA Corporation	1.00 USD	-17973099900.0%
ARS Pharmaceuticals, Inc.	- USD	-Infinity%
Bionomics Limited	-458.3 Million USD	139.216%
Alpha Tau Medical Ltd.	- USD	-Infinity%
uniQure N.V.	12.02 Million USD	-1394.769%
Estrella Immunopharma, Inc.	-288.76 Thousand USD	62342.131%
Poseida Therapeutics, Inc.	1.00 USD	-17973099900.0%
Forte Biosciences, Inc.	- USD	-Infinity%
Anebulo Pharmaceuticals, Inc.	- USD	-Infinity%
Enlivex Therapeutics Ltd.	-229 Thousand USD	78585.153%
Conduit Pharmaceuticals Inc.	- USD	-Infinity%
SeaStar Medical Holding Corporation	- USD	-Infinity%
FibroBiologics, Inc. Common Stock	- USD	-Infinity%
Altimmune, Inc.	- USD	-Infinity%
LENZ Therapeutics, Inc.	- USD	-Infinity%
Alpha Tau Medical Ltd.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	-9274.91%
Zevra Therapeutics, Inc.	9.84 Million USD	-1726.349%
Benitec Biopharma Inc.	63 Thousand USD	-285187.302%
Spyre Therapeutics, Inc.	- USD	-Infinity%
NKGen Biotech, Inc. Common Stock	- USD	-Infinity%
Zura Bio Limited	- USD	-Infinity%
PolyPid Ltd.	- USD	-Infinity%
NKGen Biotech, Inc. Warrants	- USD	-Infinity%
argenx SE	310.55 Million USD	42.125%
Immunome, Inc.	- USD	-Infinity%
Verona Pharma plc	1.00 USD	-17973099900.0%
enGene Holdings Inc. Warrants	76 Thousand USD	-236388.158%
Shattuck Labs, Inc.	- USD	-Infinity%
CervoMed Inc.	- USD	-Infinity%
Plus Therapeutics, Inc.	- USD	-Infinity%
Dianthus Therapeutics, Inc.	- USD	-Infinity%
Moolec Science SA	465.74 Thousand USD	-38489.752%
Enveric Biosciences, Inc.	- USD	-Infinity%
Design Therapeutics, Inc.	- USD	-Infinity%
Leap Therapeutics, Inc.	- USD	-Infinity%
Seelos Therapeutics, Inc.	1.00 USD	-17973099900.0%
Achilles Therapeutics plc	1.00 USD	-17973099900.0%
CERo Therapeutics Holdings, Inc.	- USD	-Infinity%
CG Oncology, Inc. Common stock	- USD	-Infinity%
Fractyl Health, Inc. Common Stock	73 Thousand USD	-246106.849%
Rani Therapeutics Holdings, Inc.	- USD	-Infinity%
MoonLake Immunotherapeutics	- USD	-Infinity%
Tourmaline Bio, Inc.	- USD	-Infinity%
Beam Therapeutics Inc.	- USD	-Infinity%
Mirum Pharmaceuticals, Inc.	22.31 Million USD	-705.535%
AEON Biopharma, Inc.	- USD	-Infinity%
Aadi Bioscience, Inc.	6.42 Million USD	-2696.499%
Enliven Therapeutics, Inc.	- USD	-Infinity%
Kiora Pharmaceuticals, Inc.	1.00 USD	-17973099900.0%
NeurAxis, Inc.	21.22 Thousand USD	-846888.69%
Iovance Biotherapeutics, Inc.	10.37 Million USD	-1632.848%
Lumos Pharma, Inc.	- USD	-Infinity%
Opiant Pharmaceuticals, Inc.	-2.95 Billion USD	106.072%
Palisade Bio, Inc.	- USD	-Infinity%
Nutriband Inc.	168.6 Thousand USD	-106498.855%
Taysha Gene Therapies, Inc.	- USD	-Infinity%
Neurogene Inc.	1.49 Million USD	-11914.104%
Kintara Therapeutics, Inc.	- USD	-Infinity%
CARGO Therapeutics, Inc. Common Stock	- USD	-Infinity%
Athira Pharma, Inc.	- USD	-Infinity%
HCW Biologics Inc.	- USD	-Infinity%
XOMA Corporation	1.00 USD	-17973099900.0%
Nektar Therapeutics	16.1 Million USD	-1016.272%
Arvinas, Inc.	- USD	-Infinity%
Tevogen Bio Holdings Inc.	- USD	-Infinity%
Merus N.V.	1.00 USD	-17973099900.0%
Omega Therapeutics, Inc.	- USD	-Infinity%
Quince Therapeutics, Inc.	- USD	-Infinity%
Rezolute, Inc.	- USD	-Infinity%
Clene Inc.	37 Thousand USD	-485659.459%
Indaptus Therapeutics, Inc.	- USD	-Infinity%
BeyondSpring Inc.	- USD	-Infinity%
Synlogic, Inc.	- USD	-Infinity%
Allarity Therapeutics, Inc.	- USD	-Infinity%
Phio Pharmaceuticals Corp.	- USD	-Infinity%
Peak Bio, Inc.	1.91 Million USD	-9274.91%
Werewolf Therapeutics, Inc.	- USD	-Infinity%
Krystal Biotech, Inc.	6.98 Million USD	-2473.099%
Karyopharm Therapeutics Inc.	3.04 Million USD	-5806.375%
SpringWorks Therapeutics, Inc.	3.1 Million USD	-5692.169%
Lipella Pharmaceuticals Inc.	- USD	-Infinity%
MannKind Corporation	28.54 Million USD	-529.641%
Ikena Oncology, Inc.	- USD	-Infinity%
Cyclerion Therapeutics, Inc.	- USD	-Infinity%
Gyre Therapeutics, Inc.	4.28 Million USD	-4098.342%
Gossamer Bio, Inc.	- USD	-Infinity%
CohBar, Inc.	- USD	-Infinity%
Cognition Therapeutics, Inc.	- USD	-Infinity%
NRx Pharmaceuticals, Inc.	-6000.00 USD	2995616.667%
Legend Biotech Corporation	19.43 Million USD	-824.875%
Mural Oncology plc	150 Thousand USD	-119720.667%
Disc Medicine, Inc.	- USD	-Infinity%
Champions Oncology, Inc.	1.00 USD	-17973099900.0%
REGENXBIO Inc.	- USD	-Infinity%
Ensysce Biosciences, Inc.	-97.56 Thousand USD	184324.229%
Anavex Life Sciences Corp.	- USD	-Infinity%
Cellectar Biosciences, Inc.	- USD	-Infinity%
Edgewise Therapeutics, Inc.	- USD	-Infinity%
Vaxart, Inc.	1.00 USD	-17973099900.0%
PharmaCyte Biotech, Inc.	- USD	-Infinity%
Aldeyra Therapeutics, Inc.	- USD	-Infinity%
Cellectis S.A.	- USD	-Infinity%
Longeveron Inc.	- USD	-Infinity%
Repare Therapeutics Inc.	2.00 USD	-8986549900.0%
Sarepta Therapeutics, Inc.	322.85 Million USD	44.331%
Inozyme Pharma, Inc.	- USD	-Infinity%
Revolution Medicines, Inc.	1.00 USD	-17973099900.0%
Nymox Pharmaceutical Corporation	28 Thousand USD	-641796.429%
Third Harmonic Bio, Inc.	- USD	-Infinity%
ArriVent BioPharma, Inc. Common Stock	- USD	-Infinity%
AN2 Therapeutics, Inc.	- USD	-Infinity%
Anixa Biosciences, Inc.	- USD	-Infinity%
Vertex Pharmaceuticals Incorporated	738.8 Million USD	75.673%
Denali Therapeutics Inc.	1.00 USD	-17973099900.0%
Revelation Biosciences, Inc.	- USD	-Infinity%
Veru Inc.	6.69 Million USD	-2583.707%
Corvus Pharmaceuticals, Inc.	- USD	-Infinity%
Cingulate Inc.	-14.62 Thousand USD	1229282.054%
Passage Bio, Inc.	- USD	-Infinity%
Context Therapeutics Inc.	- USD	-Infinity%
Exicure, Inc.	- USD	-Infinity%
Day One Biopharmaceuticals, Inc.	- USD	-Infinity%
Oramed Pharmaceuticals Inc.	- USD	-Infinity%
Scinai Immunotherapeutics Ltd.	-1.87 Million USD	9688.169%
Nuvalent, Inc.	- USD	-Infinity%
ABVC BioPharma, Inc.	- USD	-Infinity%
Carisma Therapeutics, Inc.	- USD	-Infinity%
Unicycive Therapeutics, Inc.	- USD	-Infinity%
OmniAb, Inc.	1.00 USD	-17973099900.0%
Anew Medical, Inc.	- USD	-Infinity%
Fennec Pharmaceuticals Inc.	2.14 Million USD	-8279.189%
Lipocine Inc.	- USD	-Infinity%
Lexeo Therapeutics, Inc. Common Stock	- USD	-Infinity%
Nautilus Biotechnology, Inc.	- USD	-Infinity%
SAB Biotherapeutics, Inc.	- USD	-Infinity%
G1 Therapeutics, Inc.	12.44 Million USD	-1344.551%
Bellerophon Therapeutics, Inc.	- USD	-Infinity%
Sage Therapeutics, Inc.	1.33 Million USD	-13393.318%
Ocugen, Inc.	- USD	-Infinity%
Mind Medicine (MindMed) Inc.	- USD	-Infinity%
Q32 Bio Inc.	- USD	-Infinity%
Brainstorm Cell Therapeutics Inc.	-51 Thousand USD	352513.725%
Alumis Inc. Common Stock	- USD	-Infinity%
Equillium, Inc.	- USD	-Infinity%
Kyverna Therapeutics, Inc.	- USD	-Infinity%
Coya Therapeutics, Inc.	- USD	-Infinity%
CNS Pharmaceuticals, Inc.	- USD	-Infinity%
Dominari Holdings Inc.	1.00 USD	-17973099900.0%
Edesa Biotech, Inc.	- USD	-Infinity%
vTv Therapeutics Inc.	- USD	-Infinity%
Agios Pharmaceuticals, Inc.	19.07 Million USD	-842.184%
Harmony Biosciences Holdings, Inc.	5.36 Million USD	-3251.315%
Prelude Therapeutics Incorporated	- USD	-Infinity%
Candel Therapeutics, Inc.	- USD	-Infinity%
iTeos Therapeutics, Inc.	- USD	-Infinity%
Nkarta, Inc.	- USD	-Infinity%
BioCardia, Inc.	- USD	-Infinity%
Iterum Therapeutics plc	- USD	-Infinity%

Global Stocks Search

Bio-Techne Corporation (TECH)

Inventory Summary of Bio-Techne Corporation

Annual Inventory Chart of Bio-Techne Corporation (2024 - 1989)

Historical Annual Inventory of Bio-Techne Corporation (2024 - 1989)

Peer Inventory Comparison of Bio-Techne Corporation